Upadacitinib (ABT-494) (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM.
Molecular Weight:
380.37
CAS Number:
[1310726-60-3]
Formula:
C17H19F3N6O
Target:
ABT-494
* VAT and and shipping costs not included. Errors and price changes excepted